首页> 外国专利> 109 KNOCK-IN MOUSE HOMOLOGOUS RECOMBINATED BY BANK VOLE'S PRION PROTEIN GENE WHICH 109TH AMINO ACID IS ISOLEUCINE AND APPLICATIONS THEREOF

109 KNOCK-IN MOUSE HOMOLOGOUS RECOMBINATED BY BANK VOLE'S PRION PROTEIN GENE WHICH 109TH AMINO ACID IS ISOLEUCINE AND APPLICATIONS THEREOF

机译:109氨基酸为异亮氨酸的班克沃氏PR蛋白基因重组的109敲入小鼠同源物及其应用

摘要

The present invention relates to a knock-in mouse homologous recombinated with a bank vole′s prion protein gene in which the 109th amino acid is isoleucine; and an application of the same. More specifically, the present invention relates to a knock-in mouse whose inherent prion protein gene is knocked-in with a cellular prion protein gene of a bank vole in which the 109th amino acid is isoleucine, by a homologous recombination method; and an application of the same. According to the present invention, a knock-in mouse may be produced whose inherent prion protein gene is replaced (substituted) with the gene of the prion protein of a bank vole in which the 109th amino acid is isoleucine by a homologous recombination method, and the knock-in mouse thus produced may be used beneficially as an animal model used to evaluate the anti-prion validity of a candidate material of a drug developed to treat prion disease including CJD. Further, the present invention may be beneficially used in studies to identify a role in the emergence of prions or to improve the performance of an anti-prion material.
机译:本发明涉及与其中第109位氨基酸为异亮氨酸的银行田鼠的ion病毒蛋白基因重组的敲入小鼠。和相同的应用。更具体地,本发明涉及通过同源重组方法将固有inherent病毒蛋白基因与其中第109位氨基酸为异亮氨酸的岸田鼠的细胞病毒蛋白基因敲入的敲入小鼠。和相同的应用。根据本发明,可以产生通过同源重组方法将内在的inherent病毒蛋白基因用其中第109位氨基酸为异亮氨酸的岸田鼠的ion病毒蛋白的基因替换(取代)的敲入小鼠,以及因此,由此产生的敲入小鼠可以有利地用作动物模型,用于评估开发用于治疗包括CJD的病毒疾病的药物的候选材料的抗-病毒有效性。此外,本发明可以有利地用于研究中以鉴定在病毒出现中的作用或改善抗anti病毒材料的性能。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号